Hotline for Health Services for Displaced Lebanese 1787
Hotline for the Patient Admission to Hospitals 01/832700
COVID-19 Vaccine Registration Form covax.moph.gov.lb
MoPH Hotline 1214
Are you a new member? Sign up now
 
Let us help you
Read about the latest topics.

WHO Donates Six New Vehicles to MoPH’s Epidemiological Surveillance Unit

 
MoPH and WHO organized handover event of six new Renault Express vehicles 2023  to the Ministry of Public Health’s Epidemiological Surveillance Unit today at the Ministry’s premises in the presence of Health Minister Dr Firass Abiad, ESU head Dr Nada Ghosn, and WHO Lebanon Representative Dr Abdinasir Abubakar. WHO Lebanon donated these vehicles to help facilitate the work of the ESU team in the field across Lebanon.

Dr Abiad said, “These 6 vehicles will make surveillance officers' work easier and contribute to the MoPH's focus on enhancing surveillance system for timely detection and response. MoPH and WHO have a strong partnership and our collaboration is making a difference in improving the overall health system in Lebanon.”

Dr Abdinasir said, “The ESU team is very hard-working and deserves to be supported and we will continue to support them whenever we get the opportunity. By having strong surveillance system, we can prevent, and control emerging infectious diseases and contribute to the overall pandemic preparedness capacity, while fulfilling one of the key pillars of the IHR’s core capacities.”

On her part, Dr Ghosn stated the importance of these vehicles to the work of the surveillance teams, and she reiterated that “It is crucial to have a reliable transportation that can facilitate the teams' work from Beirut to Mouhafazat or from south to north, covering Beqaa and Mount Lebanon as well. The use of these vehicles will expedite sample collection during alert verification visits to the field.”
    ...
    8
    ...
ATC Name B/G Ingredients Dosage Form Price
C10BA05 ATOZET B Atorvastatin - 40mg, Ezetimibe - 10mg Tablet, film coated 2,046,672 L.L
D01AE16 AMOROLFINE BGR G Amorolfine - 5% 5% Nail lacquer 753,896 L.L
D01BA02 APO-TERBINAFINE G Terbinafine HCl - 250mg 250mg Tablet 1,409,691 L.L
D04AB01 AVOCAINE G Lidocaine - 10% 10% Spray 620,855 L.L
D06AX01 ACIDE FUSIDIQUE BGR G Fusidic acid - 2% 2% Cream 202,920 L.L
D06AX09 AVALON AVOBAN G Mupirocin - 2% w/w 2% Ointment 460,938 L.L
D06BB10 ALDARA B Imiquimod - 5% 5% Cream 6,301,277 L.L
D06BB53 ACTI-VIR H G Aciclovir - 5%, Hydrocortisone acetate - 1% Cream 833,182 L.L
D07AC14 ADVANTAN B Methylprednisolone aceponate - 1mg/g 1mg/g Ointment 385,683 L.L
D07AC14 ADVANTAN B Methylprednisolone aceponate - 1mg/g 1mg/g Cream 385,683 L.L
D07XC04 AZONIT - D G Diflucortolone valerate - 1mg/g, Isoconazole nitrate - 10mg/g Cream 225,766 L.L
D10AD01 A-RET G Tretinoin - 0.05% 0.05% Cream 335,961 L.L
D10AD01 AVOTIN-A G Tretinoin - 0.05% 0.05% Cream 440,780 L.L
D10AD06 AKLIEF B Trifarotene - 50mcg/g 50mcg/g Cream 4,359,425 L.L
D10BA01 A-CNOTREN G Isotretinoin - 20mg 20mg Capsule, soft gelatin 1,468,376 L.L
D11AX01 ALOPEXY G Minoxidil - 20mg/ml 2% Solution 532,162 L.L
D11AX01 ALOPEXY G Minoxidil - 2% 2% Solution 532,162 L.L
D11AX01 ALOPEXY G Minoxidil - 50mg/ml 5% Solution 896,343 L.L
D11AX01 ALOPEXY G Minoxidil - 5% 5% Solution 896,343 L.L
D11AX11 AVOQUIN G Hydroquinone - 4% 4% Cream 916,501 L.L
D11AX18 ALMIRAL G Diclofenac sodium - 1% w/w 1% w/w Gel 396,434 L.L
G04BD08 ASOLFENA G Solifenacin succinate - 5mg 5mg Tablet, film coated 971,598 L.L
G04BD08 ASOLFENA G Solifenacin succinate - 10mg 10mg Tablet, film coated 971,598 L.L
G04BE08 APO-TADALAFIL G Tadalafil - 20mg 20mg Tablet 1,111,358 L.L
G04BE08 APO-TADALAFIL G Tadalafil - 5mg 5mg Tablet 1,635,456 L.L
G04BE08 APO-TADALAFIL G Tadalafil - 10mg 10mg Tablet 888,280 L.L
G04BE08 AMOS G Tadalafil - 20mg 20mg Film, orodispersible 2,175,745 L.L
G04BE08 AMOS G Tadalafil - 10mg 10mg Film, orodispersible 1,662,781 L.L
G04BE08 AMOS G Tadalafil - 5mg 5mg Film, orodispersible 2,743,998 L.L
G04CA01 ALFOCIN G Alfuzosin HCl - 10mg 10mg Tablet, extended release 858,779 L.L
    ...
    8
    ...
Sitemap
© Copyrights reserved to Ministry of Public Health 2025